NetworkNewsBreaks – Zacks Research Report Foreca
Post# of 1354
Pressure BioSciences (OTCQB: PBIO) was recently covered in a Zacks Research Report issued on July 26, 2018, which forecasted PBIO to grow at a compound annual growth rate (CAGR) of 76 percent in the next five fiscal years from 2018 to 2022 (http://nnw.fm/F3GhM). A recent article discussing the report reads: “In the Zacks Small-Cap Research Report, the company’s fair value for PBIO shares is raised to $12/share from a previous $10/share. Zacks’ optimism regarding Pressure BioSciences is tied to a number of recent achievements and collaborative research programs, expansion of the company’s sales and marketing capabilities and a newly established multinational co-marketing partner, ISS Inc.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer